SPRC

SciSparc (SPRC)

SciSparc Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SPRC

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/31	20:17	GlobeNewswire Inc.	SciSparc Secures Strategic Advantage with Grant of European Patent	NASDAQ:SPRC	SciSparc Ltd
2024/04/11	21:15	GlobeNewswire Inc.	SciSparc to Acquire AutoMax	NASDAQ:SPRC	SciSparc Ltd
2024/03/21	21:58	GlobeNewswire Inc.	SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research	NASDAQ:SPRC	SciSparc Ltd
2024/03/18	20:29	GlobeNewswire Inc.	SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	NASDAQ:SPRC	SciSparc Ltd
2024/03/14	21:49	GlobeNewswire Inc.	SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial	NASDAQ:SPRC	SciSparc Ltd
2024/03/12	21:14	GlobeNewswire Inc.	SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	NASDAQ:SPRC	SciSparc Ltd
2024/03/08	23:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/03/08	21:11	GlobeNewswire Inc.	SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	NASDAQ:SPRC	SciSparc Ltd
2024/03/07	21:49	GlobeNewswire Inc.	SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe	NASDAQ:SPRC	SciSparc Ltd
2024/03/07	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SPRC	SciSparc Ltd
2024/03/07	06:41	GlobeNewswire Inc.	SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology	NASDAQ:SPRC	SciSparc Ltd
2024/02/29	23:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/02/29	22:35	GlobeNewswire Inc.	SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing	NASDAQ:SPRC	SciSparc Ltd
2024/02/28	06:15	Edgar (US Regulatory)	Form F-1 - Registration statement for certain foreign private issuers	NASDAQ:SPRC	SciSparc Ltd
2024/02/27	22:35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/02/27	21:58	GlobeNewswire Inc.	SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds	NASDAQ:SPRC	SciSparc Ltd
2024/02/27	21:58	GlobeNewswire Inc.	Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds	NASDAQ:SPRC	SciSparc Ltd
2024/02/21	06:27	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/02/20	21:14	GlobeNewswire Inc.	Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds	NASDAQ:SPRC	SciSparc Ltd
2024/02/20	21:14	GlobeNewswire Inc.	SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds	NASDAQ:SPRC	SciSparc Ltd
2024/02/13	06:27	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/01/30	06:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/01/29	21:18	GlobeNewswire Inc.	SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder	NASDAQ:SPRC	SciSparc Ltd
2024/01/25	23:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/01/24	21:42	GlobeNewswire Inc.	SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement	NASDAQ:SPRC	SciSparc Ltd
2024/01/22	20:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/01/19	23:28	GlobeNewswire Inc.	SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million	NASDAQ:SPRC	SciSparc Ltd
2024/01/04	21:18	GlobeNewswire Inc.	SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments	NASDAQ:SPRC	SciSparc Ltd
2024/01/04	21:18	GlobeNewswire Inc.	Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based Treatments	NASDAQ:SPRC	SciSparc Ltd
2023/12/13	22:18	GlobeNewswire Inc.	SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform	NASDAQ:SPRC	SciSparc Ltd